secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2024-08-21T23:59:59+00:00
Accession:  0001213900-24-071491
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 5.02, 2.01, 5.06, 3.02, 5.03, 2.03, 3.03, 5.01, 5.05, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion closes SPAC merger with Moringa; begins trading on Nasdaq under SLXN
-----------------------------------------------------------------------------

- 9,768,396 New Silexion ordinary shares outstanding post-closing; 87,722 Moringa public shares survived redemptions.
- Redemption of 427,297 Moringa shares at ~$11.575 for total ~$4.95M from trust account.
- Raised $2M via PIPE at $10/share from Greenstar LP; secured up to $15M ELOC with White Lion Capital.
- Issued $1.25M convertible note to EarlyBird (6% interest, due 2025) plus $3.433M sponsor promissory note.
- Adopted 2024 Equity Incentive Plan; lock-ups for insiders with 6-month cliff and potential $12 price trigger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000121390024071491/0001213900-24-071491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000121390024071491/ea0211976-8k_silexion.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-071491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer